APA (7th ed.) Citation

Narr, A. (2023). Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies. https://doi.org/10.11588/heidok.00033929

Chicago Style (17th ed.) Citation

Narr, Andreas. Classification of Acute Myeloid Leukemia as a Ferroptosis-sensitive Malignancy Suggesting the Development of Arsenic Trioxide Mediated Ferroptosis-inducing Combination Therapies. Heidelberg, 2023. https://doi.org/10.11588/heidok.00033929.

MLA (9th ed.) Citation

Narr, Andreas. Classification of Acute Myeloid Leukemia as a Ferroptosis-sensitive Malignancy Suggesting the Development of Arsenic Trioxide Mediated Ferroptosis-inducing Combination Therapies. 2023. https://doi.org/10.11588/heidok.00033929.